← Back to Patent Explorer
US4298523A Expired / Lapsed US ⏱️ 0.0 years remaining

Methods and compositions for preparation of H-ARG-X-Z-Y-TYR-R

Assignee: Ortho Pharmaceutical Corp
•
Filing: 1980-06-17
•
Granted: 1981-11-03
•
Expires: 2000-06-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Solution phase methods and compositions for preparing H-ARG-X-Z-Y-TYR-R wherein X is LYS and Y is VAL or X and Y are both SAR, Z is ASP or GLU, and R is NH 2 or OH.

Inventors

  • 👤 George Heavner

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 12:23
CPC Classifications
C; C07; C07K; C07K5/00; C07K5/04; C07K5/08; C07K5/0819; C07K14/00; C07K14/435; C07K14/575; C07K14/66; C07K5/06; C07K5/06008; C07K5/06017; C07K5/06026; C07K5/06086; C07K5/06095; C07K7/00; C07K7/04; C07K7/06; A; A61; A61K; A61K38/00; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55

Claims Analysis

Total Claims: 10
Claim 1
Independent Claim 236 words
The protected tetrapeptide of formula alpha-T-X-omega-U-Z-Y-TYR-R', wherein: R' is OU or NH 2 ; X is epsilon-T"-LYS and Y is VAL or X and Y are both SAR; Z is ASP or GLU; and T and T" are each a member selected from the group consisting of: (a) ##STR19## wherein R 1 is phenyl; tolyl; xylyl; adamantyl; allyl; beta-cyanoethyl; fluorenylmethyl; benzyl, benzyl wherein the phenyl ring is substituted with from one to three members selected from halo, nitro, loweralkyl, and loweralkoxy, diisopropylmethyl; diphenylmethyl; cyclohexyl; cyclopentyl; vinyl; t-butyl; t-amyl; dimethyltrifluoromethylmethyl; or dimethylbiphenylmethyl; (b) ##STR20## wherein R 2 is loweralkyl of two to four carbons or loweralkyl of one to four carbons substituted with from one to five halo groups; (c) ##STR21## wherein V is S or O and R 3 and R 1 are each benzyl or loweralkyl; (d) ##STR22## wherein R 5 and R 6 taken individually are each loweralkyl or R 5 and R 6 taken together is ##STR23## where R 7 and R 8 are each hydrogen or loweralkyl; (e) ##STR24## wherein R 9 is hydrogen or nitro; and (f) ##STR25## wherein R 10 is hydrogen, methyl, halo, or nitro provided that T is monodentate when X is SAR; and U is benzyl or benzyl in which the phenyl group is substituted with from one to three members each selected from halo, nitro, C 1 -C 3 loweralkyl, and C 1 -C 3 loweralkoxy.
Claim 2
Dependent Claim 236 words
The protected tetrapeptide of formula alpha-T-X-omega-U-Z-Y-TYR-R', wherein: R' is OU or NH 2 ; X is epsilon-T"-LYS and Y is VAL or X and Y are both SAR; Z is ASP or GLU; and T and T" are each a member selected from the group consisting of: (a) ##STR19## wherein R 1 is phenyl; tolyl; xylyl; adamantyl; allyl; beta-cyanoethyl; fluorenylmethyl; benzyl, benzyl wherein the phenyl ring is substituted with from one to three members selected from halo, nitro, loweralkyl, and loweralkoxy, diisopropylmethyl; diphenylmethyl; cyclohexyl; cyclopentyl; vinyl; t-butyl; t-amyl; dimethyltrifluoromethylmethyl; or dimethylbiphenylmethyl; (b) ##STR20## wherein R 2 is loweralkyl of two to four carbons or loweralkyl of one to four carbons substituted with from one to five halo groups; (c) ##STR21## wherein V is S or O and R 3 and R 1 are each benzyl or loweralkyl; (d) ##STR22## wherein R 5 and R 6 taken individually are each loweralkyl or R 5 and R 6 taken together is ##STR23## where R 7 and R 8 are each hydrogen or loweralkyl; (e) ##STR24## wherein R 9 is hydrogen or nitro; and (f) ##STR25## wherein R 10 is hydrogen, methyl, halo, or nitro provided that T is monodentate when X is SAR; and U is benzyl or benzyl in which the phenyl group is substituted with from one to three members each selected from halo, nitro, C 1 -C 3 loweralkyl, and C 1 -C 3 loweralkoxy.
Claim 3
Dependent Claim 8 words
The tetrapeptide of claim 1 which is alpha-T-SAR-omega-U-Z-SAR-TYR-R'.
Claim 4
Dependent Claim 8 words
The tetrapeptide of claim 2 which is BOC-SAR-beta-benzyl-ASP-SAR-TYR-R'.
Claim 5
Dependent Claim 8 words
The tetrapeptide of claim 1 which is alpha-T-epsilon-T'-LYS-omega-U-Z-VAL-TYR-R'.
Claim 6
Dependent Claim 8 words
The tetrapeptide of claim 4 which is BOC-epsilon-CBZ-LYS-beta-benzyl-ASP-VAL-TYR-R'.
Claim 7
Dependent Claim 222 words
The tetrapeptide of formula H-X-omega-U-Z-Y-TYR-R', wherein: R' is OU or NH 2 ; X is epsilon-T"-LYS and Y is VAL or X and Y are both SAR; Z is ASP or GLU; T" is a member selected from the group consisting of: (a) ##STR26## wherein R 1 is phenyl; tolyl; xylyl; adamantyl; allyl; beta-cyanoethyl; fluorenylmethyl; benzyl, benzyl wherein the phenyl ring is substituted with from one to three members selected from halo, nitro, loweralkyl, and loweralkoxy, diisopropylmethyl; diphenylmethyl; cyclohexyl; cyclopentyl; vinyl; t-butyl; t-amyl; dimethyltrifluoromethylmethyl; or dimethylbiphenylmethyl; (b) ##STR27## wherein R 2 is loweralkyl of two to four carbons or loweralkyl of one to four carbons substituted with from one to five halo groups; (c) ##STR28## wherein V is S or O and R 3 and R 4 are each benzyl or loweralkyl; (d) ##STR29## wherein R 5 and R 6 taken individually are each loweralkyl or R 5 and R 6 taken together is ##STR30## wherein R 7 and R 8 are each hydrogen or loweralkyl; (e) ##STR31## wherein R 9 is hydrogen or nitro; and (f) ##STR32## wherein R 10 is hydrogen, methyl, halo, or nitro; and U is benzyl or benzyl in which the phenyl group is substituted with from one to three members each selected from halo, nitro, C 1 -C 3 loweralkyl, and C 1 -C 3 loweralkoxy.
Claim 8
Dependent Claim 222 words
The tetrapeptide of formula H-X-omega-U-Z-Y-TYR-R', wherein: R' is OU or NH 2 ; X is epsilon-T"-LYS and Y is VAL or X and Y are both SAR; Z is ASP or GLU; T" is a member selected from the group consisting of: (a) ##STR26## wherein R 1 is phenyl; tolyl; xylyl; adamantyl; allyl; beta-cyanoethyl; fluorenylmethyl; benzyl, benzyl wherein the phenyl ring is substituted with from one to three members selected from halo, nitro, loweralkyl, and loweralkoxy, diisopropylmethyl; diphenylmethyl; cyclohexyl; cyclopentyl; vinyl; t-butyl; t-amyl; dimethyltrifluoromethylmethyl; or dimethylbiphenylmethyl; (b) ##STR27## wherein R 2 is loweralkyl of two to four carbons or loweralkyl of one to four carbons substituted with from one to five halo groups; (c) ##STR28## wherein V is S or O and R 3 and R 4 are each benzyl or loweralkyl; (d) ##STR29## wherein R 5 and R 6 taken individually are each loweralkyl or R 5 and R 6 taken together is ##STR30## wherein R 7 and R 8 are each hydrogen or loweralkyl; (e) ##STR31## wherein R 9 is hydrogen or nitro; and (f) ##STR32## wherein R 10 is hydrogen, methyl, halo, or nitro; and U is benzyl or benzyl in which the phenyl group is substituted with from one to three members each selected from halo, nitro, C 1 -C 3 loweralkyl, and C 1 -C 3 loweralkoxy.
Claim 9
Dependent Claim 8 words
The tetrapeptide of claim 6 which is H-SAR-omega-U-Z-SAR-TYR-R'.
Claim 10
Dependent Claim 8 words
The tetrapeptide of claim 6 which is H-epsilon-CBZ-LYS-omega-U-Z-VAL-TYR-R'.

References Cited (Backward Citations)

US4190646A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-11-02 1985-05-04 1985-11-03 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-11-02 1989-05-04 1989-11-03 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-11-02 1993-05-04 1993-11-03 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag